Evidence-Based Insights for Cardiology & Radiology
Access curated medical articles and track global conferences. Designed for clinicians who value rigorous, referenced medical education.
Cardiology
Interventional cardiology, heart failure, arrhythmia management
Radiology
Diagnostic imaging, AI applications, emerging modalities
Medical Conferences & Webinars
Upcoming registrations currently open. Older listings move to the archive so this homepage stays current. All times shown in UTC unless otherwise noted.
ACC TAVR & Structural Heart Disease Update
Latest updates on transcatheter aortic valve replacement and structural heart interventions.
ESC Heart Failure Congress 2026
Comprehensive congress covering the latest advances in heart failure diagnosis, management, and emerging therapies.
European Congress of Radiology (ECR) Webinar
Post-congress webinar series covering imaging highlights, workflow updates, and new diagnostic technologies.
HRS Electrophysiology & Arrhythmia Updates
Latest advances in cardiac electrophysiology, ablation techniques, and device therapy.
Open Registration Event Calendar
Browse the full continuously updated cardiology and radiology events calendar with direct registration links.
Past Event Archive
Older conference listings remain internally linked and crawlable without cluttering the current events homepage.
Research Hubs
Start from the right clinical pathway
Move from the article hub into specialty and topic clusters without making search engines guess your information architecture.
Platform Transparency
Who operates MedTrainHub
MedTrainHub is operated by Qingdao Tsingsley Technology Co., Ltd. The platform publishes evidence-based cardiology and radiology education, while commercial training and 3D anatomical model services are kept distinct from editorial content.
Educational content, specialty hubs, and commercial project discussions are separated deliberately so clinicians can evaluate the platform with full context.
Rigorous Content. Referenced Sources. Zero Hype.
Every article on MedTrainHub includes citations to peer-reviewed literature. We prioritize accuracy and clinical relevance over sensationalism.
GLP-1 Receptor Agonists and Cardiovascular Outcomes: A 2026 Clinical Review
GLP-1 receptor agonists reduce 3-point MACE by 14–20% across multiple trial populations. The SELECT trial was the first to demonstrate cardiovascular benefit in patients with obesity without diabetes...
Stay Informed. Stay Current.
Subscribe to receive weekly updates on the latest articles and upcoming events in cardiology and radiology.